Article Details

Clover Biopharmaceuticals Raises $230 Million in Oversubscribed Series C Financing

Retrieved on: 2021-02-23 02:48:45

Tags for this article:

Click the tags to see associated articles and topics

Clover Biopharmaceuticals Raises $230 Million in Oversubscribed Series C Financing. View article details on hiswai:

Excerpt

22, 2021 /PRNewswire/ -- Clover Biopharmaceuticals, a global clinical-stage biotechnology company developing transformative biologics as vaccines ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo